Omeros Corporation to Announce Second Quarter 2016 Financial Results on August 9, 2016

SEATTLE--(BUSINESS WIRE)--Omeros Corporation (NASDAQ: OMER), a biopharmaceutical company committed to discovering, developing and commercializing both small-molecule and protein therapeutics for large-market as well as orphan indications targeting inflammation, coagulopathies and disorders of the central nervous system, today announced that the company will issue its second quarter 2016 financial results for the period ended June 30, 2016, on Tuesday, August 9, 2016, after the market closes. Om